Condition
DFNA9
Total Trials
6
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting2
Completed2
Withdrawn1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07091071Not ApplicableCompleted
Evaluation of the CochSyn Device in Clinical Practice
NCT04066270Unknown
Inventory of Radiological and Vestibular Function in Cochlear Implant Candidates
NCT03716908Recruiting
Genotype-phenotype Correlation Study of Presymptomatic and Symptomatic DFNA9 Patients
NCT04070937Recruiting
Correlation of Radiological Lesions With Vestibular Function in Patients With Bilateral Vestibulopathy
NCT04331015CompletedPrimary
Artificial Intelligence in Diagnosis of DFNA9
NCT03707756WithdrawnPrimary
Systematic Review of Phenotypical Characteristics of P51S COCH Mutation
Showing all 6 trials